New prospects for the treatment of obesity - Leptin and the discovery of anti-obesity drugs -

Research output: Contribution to journalArticle

Abstract

Obesity is a typical multifactorial disease that results from complex interactions between hereditary predisposition and environmental factors, making it extremely difficult to approach from a molecular level. At the end of 1994, an obese gene product, leptin, was discovered, and, since then, obesity research has produced a variety of new findings. Leptin is secreted from the adipose tissue and to act directly on the hypothalamus, causing appetite suppression and accelerated energy metabolism, thereby denoting a relationship to obesity and weight gain. A number of hypothalamic appetite regulators have been found, and it has recently become apparent that many of these regulators are controlled by leptin. In contrast, many genes that are known to cause human obesity and to develop from single-gene mutations regulate energy metabolism by leptin, and they have attracted attention as possible anti-obesity drugs. This paper outlines new anti-obesity drug research and development that have emerged since the discovery of leptin.

Original languageEnglish
Pages (from-to)64-67
Number of pages4
JournalJapan Medical Association Journal
Volume48
Issue number2
Publication statusPublished - Feb 2005
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'New prospects for the treatment of obesity - Leptin and the discovery of anti-obesity drugs -'. Together they form a unique fingerprint.

  • Cite this